ResearcherXijing HospitalActive in the last 2 years
Jiaze An
Matched on OpenAlex author ID A5100526024. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 9
2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 paper
Papers 4
- Genetically predicted blood metabolites mediate the association between circulating inflammation-related proteins and pancreatic cancer Last author DOI 10.21203/rs.3.rs-5783157/v1↗
- Establishment of organoid models for pancreatic ductal adenocarcinoma and screening of individualized therapy strategy. Last author DOI 10.1002/ame2.12352↗
- Lipocalin 2 may be a key factor regulating the chemosensitivity of pancreatic cancer to gemcitabine. Co-author DOI 10.1016/j.bbrep.2022.101291↗
- Mediated Imaging and Improved Targeting of Farnesylthiosalicylic Acid Delivery for Pancreatic Cancer via Conjugation with Near-Infrared Fluorescence Heptamethi… Co-author DOI 10.1021/acsabm.9b01068↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Changhong Shi · 3 shared papers, 2020–2023 · strength 0.47
- Paper Establishment of organoid models for pancreatic ductal adenocarcinoma and screening of individualized therapy strategy. DOI 10.1002/ame2.12352↗
- Paper Lipocalin 2 may be a key factor regulating the chemosensitivity of pancreatic cancer to gemcitabine. DOI 10.1016/j.bbrep.2022.101291↗
- Paper Mediated Imaging and Improved Targeting of Farnesylthiosalicylic Acid Delivery for Pancreatic Cancer via Conjugation wi… DOI 10.1021/acsabm.9b01068↗
- He Zhang · 2 shared papers, 2020–2022 · strength 0.27
- Yanheng Duan · 1 shared paper, 2025 · strength 0.26
- Liang Jin · 1 shared paper, 2025 · strength 0.26
- Yong Chen · 1 shared paper, 2025 · strength 0.26
- Peng Li · 1 shared paper, 2023 · strength 0.19
- Miaomiao Gong · 1 shared paper, 2023 · strength 0.19
- Yong Zhao · 1 shared paper, 2022 · strength 0.16
- Ya Zhao · 1 shared paper, 2020 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.